Shots: The FDA has approved Myrbetriq (ER tablets) for NDO in children aged ≥3yrs. who weigh ≥35kg and Myrbetriq Granules (ER oral suspension) for NDO in pe children aged 3yrs. […]readmore
Tags : Neurogenic Detrusor Overactivity
Shots: The US FDA has accepted the Allergan’s sBLA to expand the BOTOX prescribing information for treating detrusor (bladder muscle) overactivity associated with an underlying neurologic condition in pediatric patients […]readmore
Regulatory
Uncategorized
Astellas’ VESIcare LS (solifenacin succinate) Receives the US FDA’s Approval
Shots: VESIcare LS is an oral suspension dosage prescribed medicine specifically developed to facilitate dosing and administration for children 2 years of age and older with a condition called neurogenic […]readmore